| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |